Atlas company financials

BOSTON SCIENTIFIC CORP

Standardized 19-year financial series for BOSTON SCIENTIFIC CORP, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000885725FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$20.1B

Adjusted EBITDA

—

Net result

—

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$5.1B

TTM revenue

$19B

TTM free cash flow

—

Latest quarter net result

—

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 25.8%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · boston-scientific-corp-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-02-26 · Retrieved: 2026-04-26T11:39:36.528888+00:00
SEC EDGAR companyfacts
primary · boston-scientific-corp-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-17 · Retrieved: 2026-04-26T11:39:36.528888+00:00
SEC EDGAR companyfacts
primary · boston-scientific-corp-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-17 · Retrieved: 2026-04-26T11:39:36.528888+00:00
SEC EDGAR companyfacts
primary · boston-scientific-corp-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-22 · Retrieved: 2026-04-26T11:39:36.528888+00:00
SEC EDGAR companyfacts
primary · boston-scientific-corp-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-26 · Retrieved: 2026-04-26T11:39:36.528888+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	8B	—	-14M	—	934M	-363M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing inventory · missing net financial debt · missing net result · missing research and development · missing total assets · missing total equity
FY2008	8B	—	-2B	—	1B	-362M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing net financial debt · missing net result · missing research and development
FY2009	8B	—	-894M	—	835M	-312M	—	missing accounts receivable · missing adjusted ebitda · missing net financial debt · missing net result · missing research and development
FY2010	8B	—	-656M	—	325M	-272M	5B	missing accounts receivable · missing adjusted ebitda · missing net result · missing research and development
FY2011	8B	—	904M	—	1B	-304M	4B	missing accounts receivable · missing adjusted ebitda · missing net result · missing research and development
FY2012	7B	—	-4B	—	1B	-226M	4B	missing accounts receivable · missing adjusted ebitda · missing net result · missing research and development
FY2013	7B	—	120M	—	1B	-245M	4B	missing accounts receivable · missing adjusted ebitda · missing net result · missing research and development
FY2014	7B	—	-301M	—

Filing provenance